Influence of metabolic inhibitors on ATP level and ATP-ase activity in blood platelets.
D000244:Adenosine Diphosphate / Q000378:metabolism; D000251:Adenosine Triphosphatases / Q000032:analysis / Q000378:metabolism* / Q000502:physiology; D000255:Adenosine Triphosphate / Q000378:metabolism*; D001241:Aspirin / Q000494:pharmacology; D001386:Azides / Q000494:pharmacology; D001792:Blood Platelets / Q000187:drug effects* / Q000201:enzymology / Q000378:metabolism; D002855:Chromatography, Thin Layer; D003018:Clot Retraction; D003864:Depression, Chemical; D004140:Dinitrophenols / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D005459:Fluorides / Q000494:pharmacology; D006019:Glycolysis / Q000187:drug effects; D006801:Humans; D066298:In Vitro Techniques; D007461:Iodoacetates / Q000494:pharmacology; D010085:Oxidative Phosphorylation / Q000187:drug effects; D010101:Oxygen Consumption / Q000187:drug effects; D010973:Platelet Adhesiveness / Q000187:drug effects; D012964:Sodium; D013917:Thrombin / Q000494:pharmacology
D001386:Azides; D004140:Dinitrophenols; D007461:Iodoacetates; D000244:Adenosine Diphosphate; D000255:Adenosine Triphosphate; D012964:Sodium; D013917:Thrombin; D000251:Adenosine Triphosphatases; D005459:Fluorides; D001241:Aspirin